Rapid Nutrition (EPA:ALRPD) Full Year 2023 Results
Main financial results
- Revenue: AU$1.66 million (down 44% from FY2022).
- Net loss: AU$2.02 million (80% loss reduction compared to FY2022).
- A loss of A$0.001 per share (improved from a loss of A$18.64 in 2022).
All numbers shown in the chart above are for the trailing 12 month (TTM) period.
Insights into Rapid Revenue in Nutrition
Looking ahead, sales are expected to increase by an average of 18% per year over the next three years, compared to a growth forecast of 5.3% for the European personal products industry.
market performance France.
The company’s stock fell 7.0% from the previous week.
risk analysis
What about risks?Every company has them and we discovered that 6 warning signs about rapid feeding (4 of which you can’t ignore!) you need to know about.
Valuation is complex, but we help make it simple.
Check out our comprehensive analysis, including below, to see if Rapid Nutrition is potentially overvalued or undervalued. Fair value estimates, risks and caveats, dividends, insider trading, and financial health.
See free analysis
Have feedback on this article? Curious about its content? contact Please contact us directly. Alternatively, email our editorial team at Simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts using only unbiased methodologies, and articles are not intended to be financial advice. This is not a recommendation to buy or sell any stock, and does not take into account your objectives or financial situation. We aim to provide long-term, focused analysis based on fundamental data. Note that our analysis may not factor in the latest announcements or qualitative material from price-sensitive companies. Simply Wall St has no position in any stocks mentioned.
